Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-28, Stock:LLY, The news for the past five days is as follows:
2019-05-20: NEWS1: Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock.NEWS2: Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock.NEWS3: Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock.NEWS4: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS5: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS6: Interesting LLY Put And Call Options For August 16th.NEWS7: Interesting LLY Put And Call Options For August 16th.NEWS8: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.
2019-05-21: NEWS1: Why This Biotech Stock Succeeded In Colon Cancer As Others Struggled.NEWS2: Here's Why Array BioPharma Is Surging Today.NEWS3: Here's Why Array BioPharma Is Surging Today.NEWS4: Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions.NEWS5: Merck agrees $1bn deal to buy biopharmaceutical company Peloton.
2019-05-22: NEWS1: Array BioPharma Gains on Colorectal Cancer Study Success.NEWS2: Array BioPharma Gains on Colorectal Cancer Study Success.NEWS3: Array BioPharma Gains on Colorectal Cancer Study Success.NEWS4: 3 Tech Stocks for Growth Investors to Buy Right Now.NEWS5: Eli Lilly says lower-priced insulin is now available.NEWS6: Merck to Buy Private Cancer Drugmaker Peloton Therapeutics.NEWS7: Merck to Buy Private Cancer Drugmaker Peloton Therapeutics.NEWS8: Lilly's Crohn's Disease Candidate Meets Phase II Study Goals.NEWS9: Lilly's Crohn's Disease Candidate Meets Phase II Study Goals.NEWS10: Should We Worry About Eli Lilly and Company's (NYSE:LLY) P/E Ratio?.NEWS11: Lilly's Crohn's Disease Candidate Meets Phase II Study Goals.NEWS12: Merck to Buy Private Cancer Drugmaker Peloton Therapeutics.NEWS13: Eli Lilly&apos;s Insulin Lispro Injection available at half the list price of Humalog.NEWS14: Lilly selling half-price version of popular Humalog insulin.NEWS15: Lilly's Lower-Priced Insulin Now Available.
2019-05-23: NEWS1: Earnings Preview: Veeva (VEEV), Palo Alto Networks (PANW), Workday (WDAY).NEWS2: Amgen (AMGN) Offers to Acquire Drug Discovery Platform.NEWS3: Amgen (AMGN) Offers to Acquire Drug Discovery Platform.NEWS4: Lilly (LLY) Launches Half-Priced Version of Humalog Insulin.NEWS5: Lilly (LLY) Launches Half-Priced Version of Humalog Insulin.NEWS6: Amgen (AMGN) Offers to Acquire Drug Discovery Platform.NEWS7: J&J's Invokana sNDA Gets Priority Review Status From FDA.NEWS8: J&J's Invokana sNDA Gets Priority Review Status From FDA.NEWS9: Lilly (LLY) Launches Half-Priced Version of Humalog Insulin.NEWS10: J&J's Invokana sNDA Gets Priority Review Status From FDA.
2019-05-24: NEWS1: Nektar (NKTR) Announces Formation of CNS-Focused Subsidiary.NEWS2: Nektar (NKTR) Announces Formation of CNS-Focused Subsidiary.NEWS3: Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates.NEWS4: Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates.NEWS5: Nektar (NKTR) Announces Formation of CNS-Focused Subsidiary.NEWS6: Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates.

Answer: Decrease